RPg Family Wealth Advisory LLC Takes $101,000 Position in Apyx Medical Co. (NASDAQ:APYX)

RPg Family Wealth Advisory LLC purchased a new position in shares of Apyx Medical Co. (NASDAQ:APYX) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 75,250 shares of the company’s stock, valued at approximately $101,000.

Several other hedge funds have also added to or reduced their stakes in APYX. Commonwealth Equity Services LLC acquired a new position in Apyx Medical in the 1st quarter valued at $676,000. Rathbones Group PLC raised its holdings in Apyx Medical by 148.0% in the 2nd quarter. Rathbones Group PLC now owns 251,334 shares of the company’s stock valued at $337,000 after acquiring an additional 150,000 shares in the last quarter. AIGH Capital Management LLC raised its holdings in Apyx Medical by 7.7% in the 4th quarter. AIGH Capital Management LLC now owns 2,040,540 shares of the company’s stock valued at $5,346,000 after acquiring an additional 145,309 shares in the last quarter. Kingsview Wealth Management LLC raised its holdings in Apyx Medical by 156.7% in the 1st quarter. Kingsview Wealth Management LLC now owns 31,028 shares of the company’s stock valued at $42,000 after acquiring an additional 18,943 shares in the last quarter. Finally, Perkins Capital Management Inc. raised its holdings in Apyx Medical by 7.0% in the 1st quarter. Perkins Capital Management Inc. now owns 228,500 shares of the company’s stock valued at $311,000 after acquiring an additional 15,000 shares in the last quarter. 55.33% of the stock is owned by institutional investors and hedge funds.

Apyx Medical Trading Up 0.9 %

Shares of APYX opened at $1.08 on Wednesday. Apyx Medical Co. has a 52-week low of $0.97 and a 52-week high of $4.00. The business’s fifty day moving average is $1.27 and its 200-day moving average is $1.43. The company has a debt-to-equity ratio of 2.26, a quick ratio of 4.45 and a current ratio of 5.33. The firm has a market cap of $37.42 million, a price-to-earnings ratio of -1.64 and a beta of 1.20.

Apyx Medical (NASDAQ:APYX) last issued its quarterly earnings results on Thursday, August 8th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by ($0.01). Apyx Medical had a negative net margin of 57.86% and a negative return on equity of 105.45%. The business had revenue of $12.15 million during the quarter, compared to the consensus estimate of $12.67 million. During the same quarter in the previous year, the business posted ($0.11) EPS. Equities analysts anticipate that Apyx Medical Co. will post -0.69 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, JMP Securities reaffirmed a “market perform” rating on shares of Apyx Medical in a report on Monday.

Apyx Medical Company Profile

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.